menopause and microdosing glp 1 A New Study Says That This Could Be the Key to Losing Weight MENOPAUSE & GLP1 MICRODOSING

Comparative outcomes of systemic diseases in people with type 2 diabetes, or obesity alone treated with and without GLP-1 receptor agonists: a retrospective cohort study from the global collaborative network

Gallbladder risk is a known tradeoff of GLP-1 therapy, and managing it well means working with a provider before and during treatment, not waiting until symptoms escalate

Originally designed to treat Type 2 diabetes, many people are now using them for weight management and other metabolic health concerns

People using oral contraception should either: Switch to a non-oral method, or Use a barrier method for 4 weeks after initiation and 4 weeks after each dose escalation Given the titration schedule, that can mean several months of backup contraception

With the rise in popularity of GLP-1 boosting supplements , I have noticed many people are being influenced to make purchases without fully understanding how these supplements work